181 related articles for article (PubMed ID: 23304051)
1. Low-dose rituximab therapy for antibody-mediated rejection in a highly sensitized heart-transplant recipient.
Aggarwal A; Pyle J; Hamilton J; Bhat G
Tex Heart Inst J; 2012; 39(6):901-5. PubMed ID: 23304051
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
[TBL] [Abstract][Full Text] [Related]
3. Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: a case report.
Aranda JM; Scornik JC; Normann SJ; Lottenberg R; Schofield RS; Pauly DF; Miles M; Hill JA; Sleasman JW; Skoda-Smith S
Transplantation; 2002 Mar; 73(6):907-10. PubMed ID: 11923690
[TBL] [Abstract][Full Text] [Related]
4. Late humoral rejection in a cardiac transplant recipient treated with the anti-CD20 monoclonal antibody rituximab.
Keren A; Hayes HM; O'Driscoll G
Transplant Proc; 2006 Jun; 38(5):1520-2. PubMed ID: 16797348
[TBL] [Abstract][Full Text] [Related]
5. Treatment of humoral rejection with rituximab.
Garrett HE; Groshart K; Duvall-Seaman D; Combs D; Suggs R
Ann Thorac Surg; 2002 Oct; 74(4):1240-2. PubMed ID: 12400781
[TBL] [Abstract][Full Text] [Related]
6. Treatment of vascular rejection with rituximab in cardiac transplantation.
Garrett HE; Duvall-Seaman D; Helsley B; Groshart K
J Heart Lung Transplant; 2005 Sep; 24(9):1337-42. PubMed ID: 16143254
[TBL] [Abstract][Full Text] [Related]
7. Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies.
Asante-Korang A; Jacobs JP; Ringewald J; Carapellucci J; Rosenberg K; McKenna D; McCormack J; Wilmot I; Gjeldum A; Lopez-Cepero M; Sleasman J
Cardiol Young; 2011 Dec; 21 Suppl 2():124-32. PubMed ID: 22152539
[TBL] [Abstract][Full Text] [Related]
8. Successful kidney transplantation in highly sensitized patients.
Zhang W; Chen D; Chen Z; Zeng F; Ming C; Lin Z; Zhou P; Chen G; Chen X
Front Med; 2011 Mar; 5(1):80-5. PubMed ID: 21681679
[TBL] [Abstract][Full Text] [Related]
9. Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation.
Vo AA; Peng A; Toyoda M; Kahwaji J; Cao K; Lai CH; Reinsmoen NL; Villicana R; Jordan SC
Transplantation; 2010 May; 89(9):1095-102. PubMed ID: 20110854
[TBL] [Abstract][Full Text] [Related]
10. Antibody-mediated rejection and treatment in pediatric patients: one center's experience.
Gulleroglu K; Baskin E; Bayrakci US; Turan M; Ozdemir BH; Moray G; Karakayali H; Haberal M
Exp Clin Transplant; 2013 Oct; 11(5):404-7. PubMed ID: 24128133
[TBL] [Abstract][Full Text] [Related]
11. Outcome of Desensitization Therapy in Immunologically High-Risk Kidney Transplantation: Single-Center Experience.
Sinangil A; Ucar ZA; Koc Y; Barlas S; Abouzahir S; Ecder ST; Akin EB
Transplant Proc; 2019 Sep; 51(7):2268-2273. PubMed ID: 31358450
[TBL] [Abstract][Full Text] [Related]
12. Rituximab Therapy for Rejection in Pediatric Heart Transplant.
Erdogan I; Varan B; Sezgin A; Pirat A; Zeyneloglu P
Exp Clin Transplant; 2018 Apr; 16(2):199-203. PubMed ID: 27210774
[TBL] [Abstract][Full Text] [Related]
13. Evidence for humoral rejection of a pancreatic islet graft and rescue with rituximab and IV immunoglobulin therapy.
Kessler L; Parissiadis A; Bayle F; Moreau F; Pinget M; Froelich N; Cazenave JP; Berney T; Benhamou PY; Hanau D;
Am J Transplant; 2009 Aug; 9(8):1961-6. PubMed ID: 19522877
[TBL] [Abstract][Full Text] [Related]
14. Rituximab in highly sensitized kidney transplant recipients.
Munoz AS; Rioveros AA; Cabanayan-Casasola CB; Danguilan RA; Ona ET
Transplant Proc; 2008 Sep; 40(7):2218-21. PubMed ID: 18790197
[TBL] [Abstract][Full Text] [Related]
15. The long-term outcome of treated sensitized patients who undergo heart transplantation.
Kobashigawa JA; Patel JK; Kittleson MM; Kawano MA; Kiyosaki KK; Davis SN; Moriguchi JD; Reed EF; Ardehali AA
Clin Transplant; 2011; 25(1):E61-7. PubMed ID: 20973825
[TBL] [Abstract][Full Text] [Related]
16. Kidney transplantation across a positive crossmatch: a single-center experience.
Santos C; Costa R; Malheiro J; Pedroso S; Almeida M; Martins LS; Dias L; Tafulo S; Henriques AC; Cabrita A
Transplant Proc; 2014; 46(6):1705-9. PubMed ID: 25131017
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of hemodynamic compromise caused by antibody-mediated and cellular rejection in a recipient 12 years after heart transplantation.
Imamura T; Kinugawa K; Kato N; Kagami Y; Endo M; Kaneko N; Minatsuki S; Muraoka H; Inaba T; Maki H; Hatano M; Doi K; Yao A; Takazawa Y; Ono M; Kyo S; Komuro I
Int Heart J; 2013; 54(5):328-31. PubMed ID: 24097224
[TBL] [Abstract][Full Text] [Related]
18. Reduction of alloantibodies via proteasome inhibition in cardiac transplantation.
Patel J; Everly M; Chang D; Kittleson M; Reed E; Kobashigawa J
J Heart Lung Transplant; 2011 Dec; 30(12):1320-6. PubMed ID: 21968130
[TBL] [Abstract][Full Text] [Related]
19. Successful management of antibody-mediated cardiac allograft rejection with combined immunoadsorption and anti-CD20 monoclonal antibody treatment: case report and literature review.
Kaczmarek I; Deutsch MA; Sadoni S; Brenner P; Schmauss D; Daebritz SH; Weiss M; Meiser BM; Reichart B
J Heart Lung Transplant; 2007 May; 26(5):511-5. PubMed ID: 17449422
[TBL] [Abstract][Full Text] [Related]
20. Successful kidney transplantation after desensitization using plasmapheresis, low-dose intravenous immunoglobulin, and rituximab in highly sensitized patients: a single-center experience.
Jin MK; Cho JH; Kwon O; Hong KD; Choi JY; Yoon SH; Park SH; Kim YL; Kim CD
Transplant Proc; 2012 Jan; 44(1):200-3. PubMed ID: 22310614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
